CG Oncology(CGON)
DALLAS, TXBiotechnology
Focus: CG Oncology is a public-stage biotechnology company focused on oncolytic virus immunotherapy, headquartered in Dallas, TX with a narrow therapeutic focus on bladder cancer. The company operates as a pre-revenue biotech with significant R&D intensity and a consolidated pipeline.
Profile data last refreshed 53m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About CG Oncology
AI assessmentNot HiringNo open roles listed right now. Follow CG Oncology to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from CG Oncology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$204K
Pipeline & Clinical Trials
Cretostimogene Grenadenorepvec
Non-Muscle Invasive Bladder CancerClinical Trials (1)
NCT06443944An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
N/AHelp build intelligence for CG Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.